MedStorm Innovation
MedStorm Innovation is a medical technology company pioneering in developing a method based on analysing skin conductance or emotional sweating.
MedStorm Innovation is a medical technology company pioneering in developing a method based on analysing skin conductance or emotional sweating.
Med-Storm Innovation was founded in 1999. The main focus was to validate the PainMonitor also called Skin Conductance Algesimeter when assessing pain and nociceptive stimuli. The company has CE-certified indices to assess pain and nociceptive stimuli as well as awakening from anaesthesia. More recently there have been published studies showing that the PainMonitor device can be used to assess regional NerveBlock and Withdrawal symptoms, and Med-Storm Innovation has obtained CE-certification on these indices. All the indices are in the PainMonitor device. More than 70 validation studies are published through peer-reviewed journals. All the studies show that the Skin Conductance Algesimeter Index increases during painful events and decreases when analgesia is given. There are now 8 approved patents on the algorithms of the indices and the proprietary sensors. Additionally, another 5 pendent IP-applications are applied for. Through worldwide sales and grants from the Norwegian governments and the European committee, Med-Storm Innovation has been able to build sensitive and specific skin conductance device as a standalone model. The stand alone monitor is connected to all Philips patient monitors, some Mindray, Nihon Koden and Draeger patient monitors.
We further developed the product to offer a wireless, minutarized and wearable sensor available from 2021. This sensor is a low cost, disposable and hygienic PainSensor with electrodes. Our accurate, real-time and objective pain assessment offer a simple, real-time readout number to improve pain management. The Pain Index is transferred to patient data monitoring systems, and the PainSensor integrates with existing patient monitoring systems (Masimo, Mindray, Philips). The PainSensor will be MDR-approved within 2020 and offered in january 2021.
Our team
MD.PhD. University of Oslo. In depth knowledge of the clinical and physiological applications within skin conductance to assess pain, awakening, nerve block and withdrawal symptoms. - Inventor and founder of Med-Storm Innovation AS, extensive research and publication merits.
MSc. Civil engineer, Norwegian University of Science and Technology NTNU, MSc Finance, LSE, UK In depth knowledge about product development, entrepreneurship and project financing.
MD.PhD University of Bergen Global Biopharma and Medtech senior executive and entrepreneur 21 years CEO Photocure
MD. MPH. International business experience from Mckinsey, Kistefoss, and several IT and life science start ups.
MSc. Eindhoven University of Technology, The Netherlands. Experience with medical product engineering from Philips.
MSc. Engineer Curtin University of Technology, Western Australia Bachelor of Mechanical Engineering and Medical student, University of Oslo
MD.PhD. University of Minsk Pediatrician and Anesthesiologist